The role of intravascular devices in sepsis

[1]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Wilmer,et al.  Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients , 2001, Critical care medicine.

[4]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[5]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[6]  L. Mermel,et al.  New technologies to prevent intravascular catheter-related bloodstream infections. , 2001, Emerging infectious diseases.

[7]  R Consunji,et al.  Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.

[8]  S. Seo,et al.  Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. , 2000, The American journal of medicine.

[9]  S. Saint,et al.  Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. , 2000, Diagnostic microbiology and infectious disease.

[10]  M. Delgado-Rodríguez,et al.  Epidemiological Differences Between Sepsis Syndrome With Bacteremia and Culture-Negative Sepsis , 2000, Infection Control & Hospital Epidemiology.

[11]  J. Rello,et al.  Evaluation of outcome of intravenous catheter-related infections in critically ill patients. , 2000, American journal of respiratory and critical care medicine.

[12]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[13]  R. Balk,et al.  SEVERE SEPSIS AND SEPTIC SHOCK , 2000 .

[14]  Leonard Mermel,et al.  Prevention of Intravascular CatheterRelated Infections , 1994, Annals of Internal Medicine.

[15]  S. Chevret,et al.  A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. , 2000, The Journal of hospital infection.

[16]  G. Arlet,et al.  Diagnosis of venous access port-related infections. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Pfaller.  Molecular epidemiology in the care of patients. , 1999, Archives of pathology & laboratory medicine.

[18]  M. Wilcox,et al.  Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal , 1999, The Lancet.

[19]  C. Brun-Buisson,et al.  Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures , 1999, The Lancet.

[20]  A. Jensen,et al.  Risk factors for hospital-acquired Staphylococcus aureus bacteremia. , 1999, Archives of internal medicine.

[21]  S. Opal,et al.  Clinical trials for severe sepsis. Past failures, and future hopes. , 1999, Infectious disease clinics of North America.

[22]  J. Gowardman,et al.  Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients , 1998, Intensive Care Medicine.

[23]  E. Anaissie,et al.  Predictors of adverse outcome in cancer patients with candidemia. , 1998, The American journal of medicine.

[24]  P. Barie,et al.  Practice parameters for evaluating new fever in critically ill adult patients , 1998, Critical care medicine.

[25]  Rabih Darouiche,et al.  Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream Infections , 1997, Annals of Internal Medicine.

[26]  L. Mermel,et al.  Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated Catheter , 1997, Annals of Internal Medicine.

[27]  D. Pittet,et al.  Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  D. Shapiro,et al.  Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis , 1997, Journal of clinical microbiology.

[29]  M. Wilcox,et al.  Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. , 1997, Journal of clinical pathology.

[30]  S. Heard,et al.  Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies , 1997, Journal of clinical microbiology.

[31]  J. Vallés,et al.  Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  M. Pearson.  Guideline for Prevention of Intravascular-Device–Related Infections , 1996, Infection Control & Hospital Epidemiology.

[33]  P. V. van Heerden,et al.  Central Venous Catheters Revisited— Infection Rates and an Assessment of the New Fibrin Analysing System Brush , 1996, Anaesthesia and intensive care.

[34]  M. Pearson.  Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections : an overview. The Hospital Infection Control Practices Advisory Committee , 1996 .

[35]  J. Serody,et al.  Intravascular Catheter Exchange and Duration of Candidemia , 1995 .

[36]  M. Samore,et al.  Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. , 1995, Archives of internal medicine.

[37]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[38]  L. Mermel,et al.  A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management , 1994, Critical care medicine.

[39]  P. Collignon.  Intravascular catheter associated sepsis: a common problem , 1994 .

[40]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[41]  P. Kite,et al.  Rapid diagnosis of central venou catheter sepsis , 1993, The Lancet.

[42]  M. Beach,et al.  Consequences of intravascular catheter sepsis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  P. Collignon,et al.  Bacteraemia and Fungaemia in an Australian General Hospital — Associations and Outcomes , 1993, The Medical journal of Australia.

[44]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[45]  L. Elting,et al.  Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. , 1992 .

[46]  A. Telenti,et al.  Quantitative blood cultures in candidemia. , 1991, Mayo Clinic proceedings.

[47]  L. Elting,et al.  Septicemia Due to Xanthomonas Species and Non‐Aeruginosa Pseudomonas Species: Increasing Incidence of Catheter‐Related Infections , 1990, Medicine.

[48]  R. Platt,et al.  Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. , 1990, American journal of diseases of children.

[49]  Anusha,et al.  Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory , 1990, Journal of clinical microbiology.

[50]  R. Woolson,et al.  Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.

[51]  R. Spencer,et al.  Evaluation of three methods for culturing long intravascular catheters. , 1989, The Journal of hospital infection.

[52]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[53]  M. A. Martin,et al.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. , 1989, Annals of internal medicine.

[54]  J. Wade,et al.  Bacillus infections in patients with cancer. , 1988, Archives of internal medicine.

[55]  D. Maki,et al.  Enterococcal Bacteremia: Clinical Features, the Risk of Endocarditis, and Management , 1988, Medicine.

[56]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[57]  J. Mylotte,et al.  Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. , 1987, Reviews of infectious diseases.

[58]  J. Cheesbrough,et al.  A prospective study of the mechanisms of infection associated with hemodialysis catheters. , 1986, The Journal of infectious diseases.

[59]  D. Adelstein,et al.  Corynebacterium JK: a cause of nosocomial device-related infection. , 1986, Reviews of infectious diseases.